News | Enterprise Imaging | November 28, 2018

Vital Showcases Enterprise Imaging Advances at RSNA 2018

As company celebrates 30th anniversary, new offerings include photorealistic image visualization, automated stroke processing

Vital Showcases Enterprise Imaging Advances at RSNA 2018

Global Illumination from Vital Images

November 28, 2018 — Vital, a Canon Group company, will highlight the latest additions to its enterprise imaging portfolio at the 2018 Radiological Society of North America (RSNA) annual meeting, Nov. 25-30 in Chicago. In 2018, the company is also celebrating its 30th anniversary.

Global Illumination

New this year, Vital is introducing Global Illumination within the existing Vitrea Advanced Visualization workflows. Global Illumination delivers 3-D renderings that provide more photorealistic views of the human anatomy, and includes sharing the renderings as images, batches and movies. During RSNA 2018, attendees can get a hands-on demonstration of this highly responsive technology and see how Global Illumination is easy to use and offers real-world rendering that enriches communication among specialists, clinicians and patients.

Automated Stroke Processing

Automated Stroke Processing is a fast, accurate and affordable solution that streamlines acute care patient stroke protocols with a fully automated computed tomography (CT) and magnetic resonance imaging (MRI) post-processing application. Powered by Olea Medical, Automated Stroke Processing offers customizable reports containing instant volumetric estimation of brain tissue with abnormal hemodynamics, that may be delivered directly to users’ email.

Encounters-Based Imaging Workflow

The new Encounters-Based Imaging Workflow augments the traditional orders-driven imaging workflow. This advancement helps providers secure exam images acquired at the point of care to complete the patient’s clinical record and increase  charge-capture. This new workflow standard is fully supported by Vital's Enterprise Imaging solution.

Advanced Analytics Platform

This year at RSNA, Vital is introducing Codex, a platform component of the Vitrea Intelligence solution. With the addition of Codex, Vitrea Intelligence provides visual analysis of the data generated by imaging equipment. Unlocking the DICOM metadata provides the most comprehensive and accurate view of imaging operations available, according to Vital. Data stored in Codex version 1.1 visualizes using a new and flexible data visualization tool, enabling customers to create customized “cockpit” views of multiple key performance indicators (KPIs) simultaneously.

For more information: www.vitalimages.com

Related Content

Konica Minolta and Shimadzu to Co-market Dynamic Digital Radiography in the U.S.
News | Digital Radiography (DR) | July 23, 2019
Konica Minolta Healthcare Americas Inc. along with Shimadzu Medical Systems USA announced a collaborative agreement to...
IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Videos | Computed Tomography (CT) | July 19, 2019
Quynh Truong, M.D., MPH, associate professor of radio
Low Doses of Radiation Promote Cancer-capable Cells
News | Radiation Dose Management | July 18, 2019
Low doses of radiation equivalent to three computed tomography (CT) scans, which are considered safe, give cancer-...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
New Lung Ambition Alliance Aims to Double Five-year Lung Cancer Survival by 2025
News | Lung Cancer | July 17, 2019
The International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...